(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester

(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester Struktur
2382089-24-7
CAS-Nr.
2382089-24-7
Englisch Name:
(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester
Synonyma:
(3S,5S)-1-Boc-3,5-dihydroxypiperidine;tert-butyl (3S,5S)-3,5-dihydroxypiperidine-1-carboxylate;(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5S)-
CBNumber:
CB85852390
Summenformel:
C10H19NO4
Molgewicht:
217.26
MOL-Datei:
2382089-24-7.mol

(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester Eigenschaften

Siedepunkt:
343.3±42.0 °C(Predicted)
Dichte
1?+-.0.06 g/cm3(Predicted)
pka
14.13±0.40(Predicted)

Sicherheit

(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd.
+8618168183658
sales1@artkmedchem.com China 39009 58
JW & Y Pharmlab Co., Ltd. 021-64340559 13651849907;
xinyu_shi@jwypharmlab.com.cn China 12041 58
Nanjing Shizhou Biology Technology Co.,Ltd 13675144456
sean.lv@synzest.com China 10787 58
PharmaBlock Sciences (Nanjing), Inc. 025-86918232 4000255188
sales_china@pharmablock.com China 9792 58
Accela ChemBio Co.,Ltd. 021-50795510 4000665055
SY06@accelachem.com China 10313 58

  • (3S,5S)-3,5-Dihydroxy-piperidine-1-carboxylic acid tert-butyl ester
  • tert-butyl (3S,5S)-3,5-dihydroxypiperidine-1-carboxylate
  • 1-Piperidinecarboxylic acid, 3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5S)-
  • (3S,5S)-1-Boc-3,5-dihydroxypiperidine
  • 2382089-24-7
Copyright 2019 © ChemicalBook. All rights reserved